Rachel E. Geyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rachel E. Geyer has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Kris Pui Kwan Ma
Department of Family Medicine, University of Washington, Seattle, WA, United States
3 shared publications Alena Pauley
Department of Emergency Medicine Duke University Durham North Carolina USA
2 shared publications- Ashley E. Kim
Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington , Seattle, Washington , USA
2 shared publications - Barry R. Lutz
Department of Bioengineering, University of Washington, Seattle, WA, USA
2 shared publications Cecilia Lara Chavez
Department of Emergency Medicine University of California San Francisco California USA
2 shared publications- Chelsey Graham
Massachusetts Institute of Technology Cambridge, MA United States
2 shared publications
Latest Publications
- Open Access
- 4 September 2026
- Published by Springer Nature in BMC Primary Care
- Vol. 27 (1)
Bridging the gap in Long COVID care: identifying core competencies for primary care curriculum development and evaluation
- 4 September 2026
- Published by Springer Nature in BMC Primary Care
- Vol. 27 (1)
Open AccessBridging the gap in Long COVID care: identifying core competencies for primary care curriculum development and evaluation
- Open Access
- 22 July 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (7) , e0325948
Participant engagement in a national longitudinal study of COVID-19: Insights from the INSPIRE study
Objective: To examine participants’ motivations and their experiences throughout a decentralized, longitudinal COVID-19 study in the U.S. Methods: We recruited 355 participants from the Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) between November 2022 – March 2023 to answer five qualitative survey questions anonymously. We used an inductive content analysis approach to analyze the data. Results: We identified five key themes from the analysis, which reflected participants’ a) motivations to join the study, b) study benefits, c) perceptions of survey questions, d) experiences with the research process, and e) preferences for disseminating research findings. Participants were motivated to learn with researchers about COVID-19. They expressed divided opinions about the relevance of INSPIRE research questions. They reported difficulties navigating the virtual research platform and the need for making survey participation less cognitively demanding. They sought more regular feedback on study findings. Conclusions: Our findings offered insights into incorporating decentralized participatory methods in longitudinal research, strengthening reciprocal research communications, making virtual research platforms user-friendly, and employing strategies to reduce participants’ cognitive burden in research. Policy Implications: Longitudinal studies should focus on optimizing these aspects of participant engagement to produce rigorous findings that inform policy and practice on lasting effects of COVID-19 including Long COVID.
- 22 July 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (7) , e0325948
Open AccessParticipant engagement in a national longitudinal study of COVID-19: Insights from the INSPIRE study
Objective: To examine participants’ motivations and their experiences throughout a decentralized, longitudinal COVID-19 study in the U.S. Methods: We recruited 355 participants from the Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) between November 2022 – March 2023 to answer five qualitative survey questions anonymously. We used an inductive content analysis approach to analyze the data. Results: We identified five key themes from the analysis, which reflected participants’ a) motivations to join the study, b) study benefits, c) perceptions of survey questions, d) experiences with the research process, and e) preferences for disseminating research findings. Participants were motivated to learn with researchers about COVID-19. They expressed divided opinions about the relevance of INSPIRE research questions. They reported difficulties navigating the virtual research platform and the need for making survey participation less cognitively demanding. They sought more regular feedback on study findings. Conclusions: Our findings offered insights into incorporating decentralized participatory methods in longitudinal research, strengthening reciprocal research communications, making virtual research platforms user-friendly, and employing strategies to reduce participants’ cognitive burden in research. Policy Implications: Longitudinal studies should focus on optimizing these aspects of participant engagement to produce rigorous findings that inform policy and practice on lasting effects of COVID-19 including Long COVID.
- 5 May 2024
- Published by Wiley in Academic Emergency Medicine
- Vol. 31 (9) , 933-936
An evaluation of COVID‐19 vaccine messaging platforms in the emergency department
- 5 May 2024
- Published by Wiley in Academic Emergency Medicine
- Vol. 31 (9) , 933-936
An evaluation of COVID‐19 vaccine messaging platforms in the emergency department
- Open Access
- 3 February 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7, e41788
Developing Digital Therapeutics for Chronic Pain in Primary Care: A Qualitative Human-Centered Design Study of Providers’ Motivations and Challenges
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Digital therapeutics have been increasingly used to improve behavioral healthcare but are underutilized in primary care settings. Objective: This study explored primary care providers’ challenges and strategies in chronic pain management to identify needs and practice gaps for future development of chronic pain-related digital therapeutics tailored to primary care settings. Methods: Using a human-centered design approach, qualitative semi-structured interviews were conducted with healthcare providers (N = 11) recruited from four primary care clinics in Washington and Colorado between July and October 2021. Providers shared their goals and priorities in chronic pain management, experiences with challenges and strategies used to care for patients, and their perceptions of applying digital therapeutics in clinical practice. Transcripts were analyzed using a thematic analysis approach. Results: Our study found four themes related to provider needs: patient-provider alliance, team-based care, tracking and monitoring, and social determinants of health. Providers desired resources to improve chronic pain conversations, pain education and counseling, and goal setting with patients. Providers needed a greater accessibility to multidisciplinary care team consultations and non-pharmacological pain treatments. Healthcare system infrastructure was needed for providers to systematically track and monitor patients’ pain and provide wraparound health and social services for underserved patients. Conclusions: Leveraging digital therapeutics in a feasible, appropriate and acceptable way to aid primary care providers in chronic pain management may require multimodal features that address provider needs at an individual care and clinic/system level.
- 3 February 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7, e41788
Open AccessDeveloping Digital Therapeutics for Chronic Pain in Primary Care: A Qualitative Human-Centered Design Study of Providers’ Motivations and Challenges
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Digital therapeutics have been increasingly used to improve behavioral healthcare but are underutilized in primary care settings. Objective: This study explored primary care providers’ challenges and strategies in chronic pain management to identify needs and practice gaps for future development of chronic pain-related digital therapeutics tailored to primary care settings. Methods: Using a human-centered design approach, qualitative semi-structured interviews were conducted with healthcare providers (N = 11) recruited from four primary care clinics in Washington and Colorado between July and October 2021. Providers shared their goals and priorities in chronic pain management, experiences with challenges and strategies used to care for patients, and their perceptions of applying digital therapeutics in clinical practice. Transcripts were analyzed using a thematic analysis approach. Results: Our study found four themes related to provider needs: patient-provider alliance, team-based care, tracking and monitoring, and social determinants of health. Providers desired resources to improve chronic pain conversations, pain education and counseling, and goal setting with patients. Providers needed a greater accessibility to multidisciplinary care team consultations and non-pharmacological pain treatments. Healthcare system infrastructure was needed for providers to systematically track and monitor patients’ pain and provide wraparound health and social services for underserved patients. Conclusions: Leveraging digital therapeutics in a feasible, appropriate and acceptable way to aid primary care providers in chronic pain management may require multimodal features that address provider needs at an individual care and clinic/system level.
- 22 November 2022
- Published by Wiley in Academic Emergency Medicine
- Vol. 30 (1) , 32-39
Perspectives of COVID‐19 vaccine–hesitant emergency department patients to inform messaging platforms to promote vaccine uptake
Objectives: Efforts to promote COVID‐19 vaccine acceptance must consider the critical role of the emergency department (ED) in providing health care to underserved patients. Focusing on patients who lacked primary care, we sought to elicit the perspectives of unvaccinated ED patients regarding COVID‐19 vaccination concerns and potential approaches that might increase their vaccine acceptance.Methods: We conducted this qualitative interview study from August to November 2021 at four urban EDs in San Francisco, California; Seattle, Washington; Durham, North Carolina; and Philadelphia, Pennsylvania. We included ED patients who were ≥18 years old, fluent in English or Spanish, had not received a COVID‐19 vaccine, and did not have primary care physicians or clinics. We excluded patients who were unable to complete an interview, in police custody, under suspicion of active COVID‐19 illness, or presented with a psychiatric chief complaint. We enrolled until we reached thematic saturation in relevant domains. We analyzed interview transcripts with a content analysis approach focused on identifying concerns about COVID‐19 vaccines and ideas regarding the promotion of vaccine acceptance and potential trusted messengers.Results: Of 65 patients enrolled, 28 (43%) identified as female, their median age was 36 years (interquartile range 29–49), and 12 (18%) interviews were conducted in Spanish. Primary concerns about COVID‐19 vaccines included risk of complications, known and unknown side effects, and fear of contracting COVID‐19 from vaccines. Trust played a major role for patients in deciding which sources to use for vaccine information and in engendering vaccine acceptance. Health care providers and family or friends were commonly cited as trusted messengers of information.Conclusions: We characterized concerns about COVID‐19 vaccines, uncovered themes that may promote vaccine acceptance, and identified trusted messengers—primarily health care professionals. These data may inform the development of nuanced COVID‐19 vaccine messaging platforms to address COVID‐19 vaccine hesitancy among underserved ED populations.
- 22 November 2022
- Published by Wiley in Academic Emergency Medicine
- Vol. 30 (1) , 32-39
Perspectives of COVID‐19 vaccine–hesitant emergency department patients to inform messaging platforms to promote vaccine uptake
Objectives: Efforts to promote COVID‐19 vaccine acceptance must consider the critical role of the emergency department (ED) in providing health care to underserved patients. Focusing on patients who lacked primary care, we sought to elicit the perspectives of unvaccinated ED patients regarding COVID‐19 vaccination concerns and potential approaches that might increase their vaccine acceptance.Methods: We conducted this qualitative interview study from August to November 2021 at four urban EDs in San Francisco, California; Seattle, Washington; Durham, North Carolina; and Philadelphia, Pennsylvania. We included ED patients who were ≥18 years old, fluent in English or Spanish, had not received a COVID‐19 vaccine, and did not have primary care physicians or clinics. We excluded patients who were unable to complete an interview, in police custody, under suspicion of active COVID‐19 illness, or presented with a psychiatric chief complaint. We enrolled until we reached thematic saturation in relevant domains. We analyzed interview transcripts with a content analysis approach focused on identifying concerns about COVID‐19 vaccines and ideas regarding the promotion of vaccine acceptance and potential trusted messengers.Results: Of 65 patients enrolled, 28 (43%) identified as female, their median age was 36 years (interquartile range 29–49), and 12 (18%) interviews were conducted in Spanish. Primary concerns about COVID‐19 vaccines included risk of complications, known and unknown side effects, and fear of contracting COVID‐19 from vaccines. Trust played a major role for patients in deciding which sources to use for vaccine information and in engendering vaccine acceptance. Health care providers and family or friends were commonly cited as trusted messengers of information.Conclusions: We characterized concerns about COVID‐19 vaccines, uncovered themes that may promote vaccine acceptance, and identified trusted messengers—primarily health care professionals. These data may inform the development of nuanced COVID‐19 vaccine messaging platforms to address COVID‐19 vaccine hesitancy among underserved ED populations.
- Open Access
- 8 August 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Primary care challenges and strategies for treating chronic pain: Informing development of digital therapeutics (Preprint)
BACKGROUND Digital therapeutics have been increasingly used to improve behavioral healthcare but are underutilized in primary care settings. OBJECTIVE This study explored primary care providers’ challenges and strategies in chronic pain management to identify needs and practice gaps for future development of chronic pain-related digital therapeutics tailored to primary care settings. METHODS Using a human-centered design approach, qualitative semi-structured interviews were conducted with healthcare providers (N = 11) recruited from four primary care clinics in Washington and Colorado between July and October 2021. Providers shared their goals and priorities in chronic pain management, experiences with challenges and strategies used to care for patients, and their perceptions of applying digital therapeutics in clinical practice. Transcripts were analyzed using a thematic analysis approach. RESULTS Our study found four themes related to provider needs: patient-provider alliance, team-based care, tracking and monitoring, and social determinants of health. Providers desired resources to improve chronic pain conversations, pain education and counseling, and goal setting with patients. Providers needed a greater accessibility to multidisciplinary care team consultations and non-pharmacological pain treatments. Healthcare system infrastructure was needed for providers to systematically track and monitor patients’ pain and provide wraparound health and social services for underserved patients. CONCLUSIONS Leveraging digital therapeutics in a feasible, appropriate and acceptable way to aid primary care providers in chronic pain management may require multimodal features that address provider needs at an individual care and clinic/system level.
- 8 August 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPrimary care challenges and strategies for treating chronic pain: Informing development of digital therapeutics (Preprint)
BACKGROUND Digital therapeutics have been increasingly used to improve behavioral healthcare but are underutilized in primary care settings. OBJECTIVE This study explored primary care providers’ challenges and strategies in chronic pain management to identify needs and practice gaps for future development of chronic pain-related digital therapeutics tailored to primary care settings. METHODS Using a human-centered design approach, qualitative semi-structured interviews were conducted with healthcare providers (N = 11) recruited from four primary care clinics in Washington and Colorado between July and October 2021. Providers shared their goals and priorities in chronic pain management, experiences with challenges and strategies used to care for patients, and their perceptions of applying digital therapeutics in clinical practice. Transcripts were analyzed using a thematic analysis approach. RESULTS Our study found four themes related to provider needs: patient-provider alliance, team-based care, tracking and monitoring, and social determinants of health. Providers desired resources to improve chronic pain conversations, pain education and counseling, and goal setting with patients. Providers needed a greater accessibility to multidisciplinary care team consultations and non-pharmacological pain treatments. Healthcare system infrastructure was needed for providers to systematically track and monitor patients’ pain and provide wraparound health and social services for underserved patients. CONCLUSIONS Leveraging digital therapeutics in a feasible, appropriate and acceptable way to aid primary care providers in chronic pain management may require multimodal features that address provider needs at an individual care and clinic/system level.
- Open Access
- 22 February 2022
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 8 (2) , e28268
Diagnostic Accuracy of an At-Home, Rapid Self-test for Influenza: Prospective Comparative Accuracy Study
Background: Rapid diagnostic tests (RDTs) for influenza used by individuals at home could potentially expand access to testing and reduce the impact of influenza on health systems. Improving access to testing could lead to earlier diagnosis following symptom onset, allowing more rapid interventions for those who test positive, including behavioral changes to minimize spread. However, the accuracy of RDTs for influenza has not been determined in self-testing populations. Objective: This study aims to assess the accuracy of an influenza RDT conducted at home by lay users with acute respiratory illness compared with that of a self-collected sample by the same individual mailed to a laboratory for reference testing. Methods: We conducted a comparative accuracy study of an at-home influenza RDT (Ellume) in a convenience sample of individuals experiencing acute respiratory illness symptoms. Participants were enrolled in February and March 2020 from the Greater Seattle region in Washington, United States. Participants were mailed the influenza RDT and reference sample collection materials, which they completed and returned for quantitative reverse-transcription polymerase chain reaction influenza testing in a central laboratory. We explored the impact of age, influenza type, duration, and severity of symptoms on RDT accuracy and on cycle threshold for influenza virus and ribonuclease P, a marker of human DNA. Results: A total of 605 participants completed all study steps and were included in our analysis, of whom 87 (14.4%) tested positive for influenza by quantitative reverse-transcription polymerase chain reaction (70/87, 80% for influenza A and 17/87, 20% for influenza B). The overall sensitivity and specificity of the RDT compared with the reference test were 61% (95% CI 50%-71%) and 95% (95% CI 93%-97%), respectively. Among individuals with symptom onset ≤72 hours, sensitivity was 63% (95% CI 48%-76%) and specificity was 94% (95% CI 91%-97%), whereas, for those with duration >72 hours, sensitivity and specificity were 58% (95% CI 41%-74%) and 96% (95% CI 93%-98%), respectively. Viral load on reference swabs was negatively correlated with symptom onset, and quantities of the endogenous marker gene ribonuclease P did not differ among reference standard positive and negative groups, age groups, or influenza subtypes. The RDT did not have higher sensitivity or specificity among those who reported more severe illnesses. Conclusions: The sensitivity and specificity of the self-test were comparable with those of influenza RDTs used in clinical settings. False-negative self-test results were more common when the test was used after 72 hours of symptom onset but were not related to inadequate swab collection or severity of illness. Therefore, the deployment of home tests may provide a valuable tool to support the management of influenza and other respiratory infections.
- 22 February 2022
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 8 (2) , e28268
Open AccessDiagnostic Accuracy of an At-Home, Rapid Self-test for Influenza: Prospective Comparative Accuracy Study
Background: Rapid diagnostic tests (RDTs) for influenza used by individuals at home could potentially expand access to testing and reduce the impact of influenza on health systems. Improving access to testing could lead to earlier diagnosis following symptom onset, allowing more rapid interventions for those who test positive, including behavioral changes to minimize spread. However, the accuracy of RDTs for influenza has not been determined in self-testing populations. Objective: This study aims to assess the accuracy of an influenza RDT conducted at home by lay users with acute respiratory illness compared with that of a self-collected sample by the same individual mailed to a laboratory for reference testing. Methods: We conducted a comparative accuracy study of an at-home influenza RDT (Ellume) in a convenience sample of individuals experiencing acute respiratory illness symptoms. Participants were enrolled in February and March 2020 from the Greater Seattle region in Washington, United States. Participants were mailed the influenza RDT and reference sample collection materials, which they completed and returned for quantitative reverse-transcription polymerase chain reaction influenza testing in a central laboratory. We explored the impact of age, influenza type, duration, and severity of symptoms on RDT accuracy and on cycle threshold for influenza virus and ribonuclease P, a marker of human DNA. Results: A total of 605 participants completed all study steps and were included in our analysis, of whom 87 (14.4%) tested positive for influenza by quantitative reverse-transcription polymerase chain reaction (70/87, 80% for influenza A and 17/87, 20% for influenza B). The overall sensitivity and specificity of the RDT compared with the reference test were 61% (95% CI 50%-71%) and 95% (95% CI 93%-97%), respectively. Among individuals with symptom onset ≤72 hours, sensitivity was 63% (95% CI 48%-76%) and specificity was 94% (95% CI 91%-97%), whereas, for those with duration >72 hours, sensitivity and specificity were 58% (95% CI 41%-74%) and 96% (95% CI 93%-98%), respectively. Viral load on reference swabs was negatively correlated with symptom onset, and quantities of the endogenous marker gene ribonuclease P did not differ among reference standard positive and negative groups, age groups, or influenza subtypes. The RDT did not have higher sensitivity or specificity among those who reported more severe illnesses. Conclusions: The sensitivity and specificity of the self-test were comparable with those of influenza RDTs used in clinical settings. False-negative self-test results were more common when the test was used after 72 hours of symptom onset but were not related to inadequate swab collection or severity of illness. Therefore, the deployment of home tests may provide a valuable tool to support the management of influenza and other respiratory infections.
- Open Access
- 5 March 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Diagnostic Accuracy of an At-Home, Rapid Self-test for Influenza: Prospective Comparative Accuracy Study (Preprint)
BACKGROUND Rapid diagnostic tests (RDTs) for influenza used by individuals at home could potentially expand access to testing and reduce the impact of influenza on health systems. Improving access to testing could lead to earlier diagnosis following symptom onset, allowing more rapid interventions for those who test positive, including behavioral changes to minimize spread. However, the accuracy of RDTs for influenza has not been determined in self-testing populations. OBJECTIVE This study aims to assess the accuracy of an influenza RDT conducted at home by lay users with acute respiratory illness compared with that of a self-collected sample by the same individual mailed to a laboratory for reference testing. METHODS We conducted a comparative accuracy study of an at-home influenza RDT (Ellume) in a convenience sample of individuals experiencing acute respiratory illness symptoms. Participants were enrolled in February and March 2020 from the Greater Seattle region in Washington, United States. Participants were mailed the influenza RDT and reference sample collection materials, which they completed and returned for quantitative reverse-transcription polymerase chain reaction influenza testing in a central laboratory. We explored the impact of age, influenza type, duration, and severity of symptoms on RDT accuracy and on cycle threshold for influenza virus and ribonuclease P, a marker of human DNA. RESULTS A total of 605 participants completed all study steps and were included in our analysis, of whom 87 (14.4%) tested positive for influenza by quantitative reverse-transcription polymerase chain reaction (70/87, 80% for influenza A and 17/87, 20% for influenza B). The overall sensitivity and specificity of the RDT compared with the reference test were 61% (95% CI 50%-71%) and 95% (95% CI 93%-97%), respectively. Among individuals with symptom onset ≤72 hours, sensitivity was 63% (95% CI 48%-76%) and specificity was 94% (95% CI 91%-97%), whereas, for those with duration >72 hours, sensitivity and specificity were 58% (95% CI 41%-74%) and 96% (95% CI 93%-98%), respectively. Viral load on reference swabs was negatively correlated with symptom onset, and quantities of the endogenous marker gene ribonuclease P did not differ among reference standard positive and negative groups, age groups, or influenza subtypes. The RDT did not have higher sensitivity or specificity among those who reported more severe illnesses. CONCLUSIONS The sensitivity and specificity of the self-test were comparable with those of influenza RDTs used in clinical settings. False-negative self-test results were more common when the test was used after 72 hours of symptom onset but were not related to inadequate swab collection or severity of illness. Therefore, the deployment of home tests may provide a valuable tool to support the management of influenza and other respiratory infections.
- 5 March 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDiagnostic Accuracy of an At-Home, Rapid Self-test for Influenza: Prospective Comparative Accuracy Study (Preprint)
BACKGROUND Rapid diagnostic tests (RDTs) for influenza used by individuals at home could potentially expand access to testing and reduce the impact of influenza on health systems. Improving access to testing could lead to earlier diagnosis following symptom onset, allowing more rapid interventions for those who test positive, including behavioral changes to minimize spread. However, the accuracy of RDTs for influenza has not been determined in self-testing populations. OBJECTIVE This study aims to assess the accuracy of an influenza RDT conducted at home by lay users with acute respiratory illness compared with that of a self-collected sample by the same individual mailed to a laboratory for reference testing. METHODS We conducted a comparative accuracy study of an at-home influenza RDT (Ellume) in a convenience sample of individuals experiencing acute respiratory illness symptoms. Participants were enrolled in February and March 2020 from the Greater Seattle region in Washington, United States. Participants were mailed the influenza RDT and reference sample collection materials, which they completed and returned for quantitative reverse-transcription polymerase chain reaction influenza testing in a central laboratory. We explored the impact of age, influenza type, duration, and severity of symptoms on RDT accuracy and on cycle threshold for influenza virus and ribonuclease P, a marker of human DNA. RESULTS A total of 605 participants completed all study steps and were included in our analysis, of whom 87 (14.4%) tested positive for influenza by quantitative reverse-transcription polymerase chain reaction (70/87, 80% for influenza A and 17/87, 20% for influenza B). The overall sensitivity and specificity of the RDT compared with the reference test were 61% (95% CI 50%-71%) and 95% (95% CI 93%-97%), respectively. Among individuals with symptom onset ≤72 hours, sensitivity was 63% (95% CI 48%-76%) and specificity was 94% (95% CI 91%-97%), whereas, for those with duration >72 hours, sensitivity and specificity were 58% (95% CI 41%-74%) and 96% (95% CI 93%-98%), respectively. Viral load on reference swabs was negatively correlated with symptom onset, and quantities of the endogenous marker gene ribonuclease P did not differ among reference standard positive and negative groups, age groups, or influenza subtypes. The RDT did not have higher sensitivity or specificity among those who reported more severe illnesses. CONCLUSIONS The sensitivity and specificity of the self-test were comparable with those of influenza RDTs used in clinical settings. False-negative self-test results were more common when the test was used after 72 hours of symptom onset but were not related to inadequate swab collection or severity of illness. Therefore, the deployment of home tests may provide a valuable tool to support the management of influenza and other respiratory infections.
- Open Access
- 17 April 2020
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 14 (4) , e0008153
Gender norms and mass deworming program access in Comé, Benin: A qualitative assessment of gender-associated opportunities and challenges to achieving high mass drug administration coverage
The World Health Organization’s Neglected Tropical Disease Roadmap has accelerated progress towards eliminating select neglected tropical diseases (NTDs). This momentum has catalyzed research to determine the feasibility of interrupting transmission of soil-transmitted helminths (STH) using community-wide mass drug administration (MDA). This study aims to identify potential gender-specific facilitators and barriers to accessing and participating in community-wide STH MDA, with the goal of ensuring programs are equitable and maximize the probability of interrupting STH transmission. This research was conducted prior to the launch of community-wide MDA for STH in Comé, Benin. A total of 10 focus group discussions (FGDs) were conducted separately among 40 men, 38 women, and 15 community drug distributors (CDDs). Salient themes included: both men and women believe that community-wide MDA would reduce the financial burden associated with self-treatment, particularly for low income adults. Community members believe MDA should be packaged alongside water, sanitation, and other health services. Women feel past community-wide programs have been disorganized and are concerned these distributions will be similar. Women also expressed interest in increased engagement in the implementation of future community-based public health programs. Men often did not perceive themselves to be at great risk for STH infection and did not express a high demand for treatment. Finally, the barriers discussed by CDDs generally did not align with gender-specific concerns, but rather represented concerns shared by both genders. A door-to-door distribution strategy for STH MDA is preferred by women in this study, as this platform empowers women to participate as health decision makers for their family. In addition, involving women in planning and implementation of community-wide programs may help to increase treatment coverage and compliance. Soil-transmitted helminths (STH) affect an estimated 1.5 billion people globally. The DeWorm3 Project is investigating if it is possible to interrupt transmission of STH with community-wide deworming of individuals of all ages. We conducted focus group discussions with adult men, women, and community drug distributors (CDDs) in Comé, Benin to identify gender-specific facilitators and barriers to accessing and participating in community-wide mass drug administration (MDA) programs. Our findings suggest that door-to-door community-wide MDA may not only improve MDA treatment coverage by increasing access but may also empower women by facilitating increased decision making on behalf of their regarding who is treated and where. Additionally, women may be an untapped resource for strategically reaching missed populations and women reported seeking increased involvement within the deworming of their families. Men did not perceive themselves to be at risk and thus did not have high demand for deworming. Both genders reported that they struggle to afford deworming drugs outside of MDA and that MDA coverage would be higher if treatment was integrated with water and sanitation services. Finally, CDDs generally identified only barriers and facilitators to MDA that were shared by both genders and may require more training to ensure MDA programs are equitable and effectively engage all at risk populations.
- 17 April 2020
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 14 (4) , e0008153
Open AccessGender norms and mass deworming program access in Comé, Benin: A qualitative assessment of gender-associated opportunities and challenges to achieving high mass drug administration coverage
The World Health Organization’s Neglected Tropical Disease Roadmap has accelerated progress towards eliminating select neglected tropical diseases (NTDs). This momentum has catalyzed research to determine the feasibility of interrupting transmission of soil-transmitted helminths (STH) using community-wide mass drug administration (MDA). This study aims to identify potential gender-specific facilitators and barriers to accessing and participating in community-wide STH MDA, with the goal of ensuring programs are equitable and maximize the probability of interrupting STH transmission. This research was conducted prior to the launch of community-wide MDA for STH in Comé, Benin. A total of 10 focus group discussions (FGDs) were conducted separately among 40 men, 38 women, and 15 community drug distributors (CDDs). Salient themes included: both men and women believe that community-wide MDA would reduce the financial burden associated with self-treatment, particularly for low income adults. Community members believe MDA should be packaged alongside water, sanitation, and other health services. Women feel past community-wide programs have been disorganized and are concerned these distributions will be similar. Women also expressed interest in increased engagement in the implementation of future community-based public health programs. Men often did not perceive themselves to be at great risk for STH infection and did not express a high demand for treatment. Finally, the barriers discussed by CDDs generally did not align with gender-specific concerns, but rather represented concerns shared by both genders. A door-to-door distribution strategy for STH MDA is preferred by women in this study, as this platform empowers women to participate as health decision makers for their family. In addition, involving women in planning and implementation of community-wide programs may help to increase treatment coverage and compliance. Soil-transmitted helminths (STH) affect an estimated 1.5 billion people globally. The DeWorm3 Project is investigating if it is possible to interrupt transmission of STH with community-wide deworming of individuals of all ages. We conducted focus group discussions with adult men, women, and community drug distributors (CDDs) in Comé, Benin to identify gender-specific facilitators and barriers to accessing and participating in community-wide mass drug administration (MDA) programs. Our findings suggest that door-to-door community-wide MDA may not only improve MDA treatment coverage by increasing access but may also empower women by facilitating increased decision making on behalf of their regarding who is treated and where. Additionally, women may be an untapped resource for strategically reaching missed populations and women reported seeking increased involvement within the deworming of their families. Men did not perceive themselves to be at risk and thus did not have high demand for deworming. Both genders reported that they struggle to afford deworming drugs outside of MDA and that MDA coverage would be higher if treatment was integrated with water and sanitation services. Finally, CDDs generally identified only barriers and facilitators to MDA that were shared by both genders and may require more training to ensure MDA programs are equitable and effectively engage all at risk populations.